Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2012-08-31 AGM Information
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Kallelse till extra bolagsstämma i Vitrolife AB (publ)
AGM Information Classification · 98% confidence The document is titled "Kallelse till extra bolagsstämma i VITROLIFE AB (publ)" which translates to "Notice of Extraordinary General Meeting in VITROLIFE AB (publ)". It details the date, location, registration requirements, and a specific agenda (Dagordning) for the meeting, including proposals for a dividend distribution (utdelning) and a directed new share issue (riktad nyemission). This content is characteristic of a formal notice calling shareholders to a meeting to vote on corporate actions. This aligns perfectly with the definition of materials shared for an Annual General Meeting (AGM) or Extraordinary General Meeting (EGM). Since the provided codes include AGM-R for AGM materials, and this is a notice for an *extra* meeting, AGM-R is the most appropriate classification, as it covers general meeting materials, even if it's not the annual one. It is not a DEF 14A (Remuneration) or DVA (Voting Results), but the call itself.
2012-08-31 Swedish
Notice of Extraordinary General Meeting of Vitrolife AB (publ)
AGM Information Classification · 98% confidence The document is explicitly titled "Notice to attend the Extraordinary General Meeting of VITROLIFE AB (publ)". It details the date, time, location, registration procedures, and the agenda for an Extraordinary General Meeting (EGM). The agenda items include resolutions on dividends and a new share issue. This content directly relates to the formal proceedings and materials associated with a shareholder meeting, specifically an EGM, which falls under the scope of AGM Information (AGM-R), even though it is an EGM, as it concerns the formal meeting structure and shareholder votes/proposals. It is not a full Annual Report (10-K), an Earnings Release (ER), or a standard proxy statement (DEF 14A/PSI), but rather the formal notice convening the meeting.
2012-08-31 English
Vitrolifes amerikanska dotterbolag har stämts
Legal Proceedings Report Classification · 95% confidence The document is explicitly titled "Pressmeddelande" (Press Release) and announces that Vitrolife's US subsidiary has been sued regarding a patient case involving a lung transplant and the company's organ preservation product. This is a specific, material event disclosure. It is not a comprehensive annual report (10-K), an interim report (IR), an earnings release (ER), or a formal regulatory filing like a DEF 14A or DVA. Since it is a specific announcement of a legal matter, it best fits the Legal Proceedings Report (LTR) category. The document is short and functions as an immediate disclosure of a lawsuit, which aligns with the nature of an LTR.
2012-07-31 Swedish
Vitrolife's subsidiary in the USA has been sued
Legal Proceedings Report Classification · 95% confidence The document is explicitly titled "Press release" and announces that the company's US subsidiary has been sued for compensation related to a product used in a lung transplantation. This type of material, announcing a significant event (a lawsuit) that is material to the company's operations and potential liabilities, is typically disseminated via a press release. Since there is no specific category for 'Lawsuit Announcement' and it is not a comprehensive financial report (10-K, IR), an audit report (AR), or a management discussion (MDA), it falls best under the general regulatory announcement category, RNS, or potentially LTR (Legal Proceedings Report). Given the content is a direct announcement of a legal action, LTR is the most specific fit among the provided options, as it details a significant lawsuit involving the company. It is not a short announcement pointing to a separate report, so RPA is not applicable.
2012-07-31 English
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is titled 'delårsrapport januari-JUNI 2012' (Interim Report January-June 2012) for Vitrolife AB. It contains comprehensive financial statements, including income statements, cash flow analysis, and management commentary for the six-month period. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it is classified as an Interim/Quarterly Report. H1 2012
2012-07-13 Swedish
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is titled 'interim report january-JUNE 2012' and contains comprehensive financial statements, key figures, CEO comments, and analysis of business performance for the specified period. It is clearly a periodic financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report. H1 2012
2012-07-13 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.